Tech Company Financing Transactions
Semarion Funding Round
Semarion, based in Cambridge, received $2.9 million from ParkWalk Advisors, Cambridge Enterprise and Martlet Capital.
Transaction Overview
Company Name
Announced On
3/14/2022
Transaction Type
Venture Equity
Amount
$2,890,000
Round
Seed
Investors
Proceeds Purpose
The funding will support the commercial development of Semarion's SemaCyte cell assaying platform.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Cavendish Laboratories JJ Thomson Ave.
Cambridge, CB3 0HE
UK
Cambridge, CB3 0HE
UK
Phone
Undisclosed
Website
Email Address
Overview
Semarion is built on fostering collaboration across disciplines to tackle foundational bottlenecks in drug discovery. We operate at the edge of the physical and life sciences by using microchip industry materials and techniques to transform cell-based research.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Wallace
Chief Executive Officer
Jeroen Verheyen
Chief Technical Officer
Tarun Vemulkar
Browse more venture capital transactions:
Prev: 3/14/2022: SeMI Technologies venture capital transaction
Next: 3/14/2022: Invact Metaversity venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs